Jose Manuel Mas

Chief of Scientific Officer

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jose Manuel Mas is the Chief of Scientific Officer at Anaxomics in Spain. His research focuses on quantitative systems pharmacology, artificial intelligence applications in healthcare, and systems biology. Recent articles include studies on treatment models for psoriasis, decision support systems for pancreatic cancer, and drug repositioning using proteomics. He is also involved in international collaborations aimed at improving prevention strategies for gastric cancer and optimizing treatments for various cancers.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Elena Jiménez-Martí

Profresora Ayudante Doctor

University of Valencia

SPAIN

View details

Isabel Castrejon, MD, PhD

Associate Professor

Universidad Complutense de Madrid

SPAIN

View details

Cristina Segú-Vergés

Chief Compliance Officer and Head of Medical Writing Department

Anaxomics (Spain)

SPAIN

View details

Sara Manrique-Arija

Associate Lecturer

Universidad de Málaga Facultad de Medicina

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jose Manuel Mas

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence–Based Data Analyses of a National Multicenter Prospective Registry

A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis

A decision support system based on artificial intelligence and systems biology for the simulation of pancreatic cancer patient status

The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally

Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning

Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate

CuBlock: a cross-platform normalization method for gene-expression microarrays

Proteomics based drug repositioning applied to improve in vitro fertilization implantation: an artificial intelligence model

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an <i>in silico</i> systems biology-based approach

Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia

Collaborators (4)

Elena Jiménez-Martí

Isabel Castrejon, MD, PhD

Cristina Segú-Vergés

Sara Manrique-Arija

Make your next move.